n-succinimidyl-5-iodo-3-pyridinecarboxylic acid has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bigner, DD; Friedman, HS; Garg, PK; Garg, S; Zalutsky, MR; Zhao, XG | 1 |
| Bigner, DD; Foulon, CF; Welsh, PC; Zalutsky, MR | 1 |
2 other study(ies) available for n-succinimidyl-5-iodo-3-pyridinecarboxylic acid and Glioma
| Article | Year |
|---|---|
Radioiodination of a monoclonal antibody using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
Topics: Animals; Antibodies, Monoclonal; Glioma; Iodine Radioisotopes; Isotope Labeling; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Nicotinic Acids; Succinimides; Tissue Distribution; Transplantation, Heterologous | 1993 |
Positively charged templates for labeling internalizing antibodies: comparison of N-succinimidyl 5-iodo-3-pyridinecarboxylate and the D-amino acid peptide KRYRR.
Topics: Animals; Antibodies, Monoclonal; Glioma; Humans; Iodine Radioisotopes; Isotope Labeling; Mice; Mice, Nude; Neoplasm Transplantation; Nicotinic Acids; Oligopeptides; Radiometry; Radiopharmaceuticals; Succinimides; Tissue Distribution; Tumor Cells, Cultured | 2001 |